Mesalamine Capsule, Extended Release — FDA Drug Shortage
The FDA lists a drug shortage record for Mesalamine Capsule, Extended Release (capsule, extended release) from Takeda Pharmaceuticals USA Inc. with status To Be Discontinued. The shortage was first posted on Sep 16, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Takeda Pharmaceuticals USA Inc.
- Package NDC
- 54092-191-12
- Dosage Form
- Capsule, Extended Release
- Presentation
- Pentasa, Capsule, Extended Release, 500 mg (NDC 54092-191-12)
- Initial Posting
- Sep 16, 2026